tiprankstipranks
Trending News
More News >
Lifecore Biomedical (LFCR)
NASDAQ:LFCR
US Market

Lifecore Biomedical (LFCR) Financial Statements

Compare
152 Followers

Lifecore Biomedical Financial Overview

Lifecore Biomedical's market cap is currently $150.66M. The company's EPS TTM is $-0.16; its P/E ratio is -9.61; Lifecore Biomedical is scheduled to report earnings on March 16, 2026, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
May 25May 24Aug 23May 22May 21
Income Statement
Total Revenue$ 128.87M$ 128.26M$ 103.27M$ 111.27M$ 100.87M
Gross Profit$ 40.30M$ 41.85M$ 27.98M$ 39.07M$ 38.94M
Operating Income$ -17.25M$ -8.84M$ -21.80M$ -11.79M$ -8.82M
EBITDA$ -8.81M$ 35.60M$ -33.17M$ 12.84M$ -987.00K
Net Income$ -38.72M$ 12.01M$ -99.56M$ -116.72M$ -32.29M
Balance Sheet
Cash & Short-Term Investments$ 8.27M$ 8.46M$ 19.09M$ 991.00K$ 1.16M
Total Assets$ 239.34M$ 253.96M$ 253.54M$ 274.70M$ 502.92M
Total Debt$ 130.82M$ 133.57M$ 112.62M$ 247.78M$ 215.86M
Net Debt$ 122.56M$ 125.11M$ 93.53M$ 246.79M$ 214.70M
Total Liabilities$ 238.01M$ 242.65M$ 257.77M$ 186.88M$ 300.14M
Stockholders' Equity$ 1.34M$ 11.31M$ -4.23M$ 87.82M$ 202.78M
Cash Flow
Free Cash Flow$ -13.62M$ -18.14M$ -38.92M$ -52.53M$ -8.75M
Operating Cash Flow$ -206.00K$ 257.00K$ -17.44M$ -22.59M$ 16.47M
Investing Cash Flow$ -6.42M$ -18.39M$ -4.81M$ 79.96M$ -12.31M
Financing Cash Flow$ 6.42M$ 7.51M$ 39.70M$ -57.02M$ -3.42M
Currency in USD

Lifecore Biomedical Earnings and Revenue History

Lifecore Biomedical Debt to Assets

Lifecore Biomedical Cash Flow

Lifecore Biomedical Forecast EPS vs Actual EPS